UEMS Medical Specialty

Psychiatry & Neurodevelopment — Page 2

Formulation science addressing mental health: catecholaminergic modulation, ADHD, mood disorders, neuropsychological function, and the gut–brain axis as a therapeutic target.

25

dossiers

Precision Microbiome & Gut-Brain Axis

Gut-Brain Axis in ADHD: Microbiota-Mediated Dopaminergic Pathway Modulation

Developing scientifically validated microbiome-targeted interventions for ADHD involves addressing the challenges of heterogeneity in clinical outcomes and identifying precise microbial mechanisms. Formulating stable, effective probiotics or synbiotics with demonstrated clinical benefits remains a major hurdle.

NeuroinflammationAttention Deficit Disorder with HyperactivityDopamineSerotonin

Custom Formulation Available

Need a Dossier Built Around Your Molecule?

Project-specific requirements and next steps are confirmed in writing through the agreed scope.

Request a written scoped quote← Return to Clinical Matrix

RELATED RESOURCES

R&D Hub — All Scientific CategoriesFull library of evidence-based research covering formulation, bioavailability and clinical nutrition.EXPLORE ›Advanced Formulation Technology PlatformProject-specific formulation assessment, evidence review and regulatory pathway are defined in the agreed scope. Manufacturing arrangements and any external testing are confirmed per project.EXPLORE ›Production Formats & MOQ ReferenceHard capsules 150K, softgels 300K, sachets 75K — connect the science to actual industrial thresholds.EXPLORE ›Physician Supplement Brand Contract ManufacturingA project brief defines the formulation, evidence, regulatory path, scope and ownership terms before manufacturing is considered.EXPLORE ›Paid Discovery: R&D Due Diligence EntryTransform research findings into a scoped, confidential manufacturing brief.EXPLORE ›Commercialization Intelligence HubRegulatory and market strategy intelligence for supplement brand decision-makers.EXPLORE ›